NO873031L - Ionebytterharpiks. - Google Patents

Ionebytterharpiks.

Info

Publication number
NO873031L
NO873031L NO873031A NO873031A NO873031L NO 873031 L NO873031 L NO 873031L NO 873031 A NO873031 A NO 873031A NO 873031 A NO873031 A NO 873031A NO 873031 L NO873031 L NO 873031L
Authority
NO
Norway
Prior art keywords
resin
drug
particles
approx
impregnating agent
Prior art date
Application number
NO873031A
Other languages
English (en)
Norwegian (no)
Other versions
NO873031D0 (no
Inventor
San-Laung Chow
Yegnaswami Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of NO873031D0 publication Critical patent/NO873031D0/no
Publication of NO873031L publication Critical patent/NO873031L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)
  • Paints Or Removers (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pyridine Compounds (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
NO873031A 1986-07-30 1987-07-20 Ionebytterharpiks. NO873031L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89216986A 1986-07-30 1986-07-30

Publications (2)

Publication Number Publication Date
NO873031D0 NO873031D0 (no) 1987-07-20
NO873031L true NO873031L (no) 1988-02-01

Family

ID=25399487

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873031A NO873031L (no) 1986-07-30 1987-07-20 Ionebytterharpiks.

Country Status (13)

Country Link
EP (1) EP0254811B1 (fr)
JP (1) JP2670777B2 (fr)
KR (1) KR960012067B1 (fr)
AT (1) ATE93164T1 (fr)
AU (1) AU582302B2 (fr)
CA (1) CA1283998C (fr)
DE (1) DE3787060T2 (fr)
DK (1) DK394787A (fr)
FI (1) FI872582A7 (fr)
IE (1) IE62100B1 (fr)
IL (1) IL82223A0 (fr)
NO (1) NO873031L (fr)
NZ (1) NZ219816A (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5186930A (en) * 1988-11-14 1993-02-16 Schering Corporation Sustained release oral suspensions
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
SE9003903D0 (sv) * 1990-12-07 1990-12-07 Astra Ab New pharmaceutical formulations
US5275820A (en) * 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
US5296228A (en) * 1992-03-13 1994-03-22 Allergan, Inc. Compositions for controlled delivery of pharmaceutical compounds
JP3213712B2 (ja) * 1992-08-04 2001-10-02 全日本空輸株式会社 コンテナ自動移載装置および移載方法
JPH06305518A (ja) * 1993-04-23 1994-11-01 Kajima Corp 収納設備
WO1999020285A1 (fr) * 1997-10-16 1999-04-29 Sanwa Kagaku Kenkyusho Co., Ltd. Preparations de gels contenant un polystyrenesulfonate
KR100440544B1 (ko) * 1998-07-31 2004-07-15 니켄 가가쿠 가부시키가이샤 양이온 교환수지 제제
JP3866179B2 (ja) * 2002-10-09 2007-01-10 ダイセル化学工業株式会社 光学異性体分離用充填剤の製造方法
JP4808405B2 (ja) 2002-11-26 2011-11-02 ホ−レンベック ギャリ− ア−ル 高度に水溶性の電解質薬剤のための水性徐放性ドラッグデリバリーシステム
CN1845722A (zh) * 2003-09-03 2006-10-11 马林克罗特公司 粒状缓释制剂及其生产
EP1893175A1 (fr) * 2005-06-09 2008-03-05 Upm Pharmaceuticals, Inc. Systeme aqueux d'apport de medicaments a liberation controlee pour medicaments electrolytiques hautement hydrosolubles
US8343546B2 (en) * 2005-09-13 2013-01-01 Coating Place, Inc. Ion exchange resin treated to control swelling
WO2007038801A2 (fr) * 2005-09-30 2007-04-05 Ilypsa, Inc. Compositions de liaison aux cations monovalents comprenant des particules coeur-ecorce avec des ecorces polyvinyliques reticulees et procedes pour les utiliser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
CA1236023A (fr) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Preparations pharmaceutiques a liberation controlee
NZ219925A (en) * 1986-07-30 1989-06-28 Pennwalt Corp Polymer-treated sulphonic acid cationic exchange resin particles

Also Published As

Publication number Publication date
AU7098987A (en) 1988-02-04
IL82223A0 (en) 1987-10-30
KR960012067B1 (ko) 1996-09-12
DK394787A (da) 1988-05-02
DE3787060T2 (de) 1993-12-02
JP2670777B2 (ja) 1997-10-29
JPS6335527A (ja) 1988-02-16
FI872582L (fi) 1988-01-31
EP0254811B1 (fr) 1993-08-18
EP0254811A2 (fr) 1988-02-03
ATE93164T1 (de) 1993-09-15
NO873031D0 (no) 1987-07-20
KR880001302A (ko) 1988-04-22
DE3787060D1 (de) 1993-09-23
IE870789L (en) 1988-01-30
CA1283998C (fr) 1991-05-07
NZ219816A (en) 1989-01-06
FI872582A0 (fi) 1987-06-09
IE62100B1 (en) 1994-12-14
DK394787D0 (da) 1987-07-29
FI872582A7 (fi) 1988-01-31
AU582302B2 (en) 1989-03-16
EP0254811A3 (en) 1989-04-05

Similar Documents

Publication Publication Date Title
US4859461A (en) Coatable ion exchange resins
US4847077A (en) Controlled release pharmaceutical preparations
US4959219A (en) Coating barriers comprising ethyl cellulose
NO873031L (no) Ionebytterharpiks.
Guo et al. Ion-exchange resins as drug delivery carriers
CA1236023A (fr) Preparations pharmaceutiques a liberation controlee
US4859462A (en) Polymer-treated ion exchange resins
DK175659B1 (da) Farmaceutisk sammensætning på enhedsdosisform til peroral administration
DK160601B (da) Farmaceutisk harpiksholdigt, sustained release praeparat med kontrolleret afgivelse af et farmaceutisk acceptabelt syreadditionssalt af dextromethorphan samt fremgangsmaade til fremstilling deraf
US4518588A (en) Process for the preparation of an inclusion complex of N-(1--phenylethyl)-3,3-diphenylpropylamine and the hydrochloride thereof respectively with cyclodextrin
Borodkin Ion-exchange resin delivery systems
Irwin et al. Drug-delivery by ion-exchange: part IIII: interaction of ester pro-drugs of propranolol with cationic exchange resins
CA1283497C (fr) Resines echangeuses d'ions traitees au polymere
JPH06504059A (ja) ポリアミン薬物−樹脂複合体
IE45998B1 (en) Prolonged release pharmaceutical preparations
US4369175A (en) Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them
JPH01313431A (ja) ジルチアゼム・マイクロビーズ、その製法および徐放性医薬組成物
KR0135736B1 (ko) 안정한 오메프라졸 레진염
JPH0118052B2 (fr)
KR20200106503A (ko) 가교결합된 이온 교환 수지를 함유하는 약학적 조성물
Chattaraj et al. Effect of formulation variables on the preparation and in vitro-in vivo evaluation of cimetidine release from ethyl cellulose micropellets
CN111989091A (zh) 含有树脂颗粒的药物组合物
GB2078758A (en) Prolonged Action Vincamine Preparations
JPS5815173B2 (ja) マイクロカプセルの調整方法